Clinical ink provides insights for the 2024 FDA’s Guidance for Conducting Clinical Trials with Decentralized Elements Decentralized Clinical Trial (DCT).
The post 2024 FDA DCT Guidance appeared first on Clinical ink.
Clinical Ink is a Pennsylvania-based clinical trial platform that provides solutions such as data management and patient engagement for the healthcare sector.